Beyfortus in Action ECMMID
Beyfortus in Action: Real-world data from the 2023-2024 RSV season
Lucía López Granados - MD, PhD
Primary Care Pediatrician. Madrid Health Service, Spain ECCMID congress, April 2024
.jpg/jcr:content/thumb%20(4).jpg)
MAT-SA-2400366-V1-July 2024
Campus
- Science
- Acquired Thrombotic Thrombocytopenic Purpura (ATTP)
- Allergic Rhinitis
- Anti-Infectives
- Asthma
- Atopic Dermatitis
- Chronic Obstructive Pulmonary Disease
- Chronic Spontaneous Urticaria
- Diabetes
- Eosinophilic Esophagitis
- Microbiota and Probiotics
- Multiple Myeloma
- Multiple Sclerosis
- Nasal Polyps
- Neurological Disorders
- Prurigo Nodularis
- Rare Diseases
- Transplant
Campus
- Science
- Acquired Thrombotic Thrombocytopenic Purpura (ATTP)
- Allergic Rhinitis
- Anti-Infectives
- Asthma
- Atopic Dermatitis
- Chronic Obstructive Pulmonary Disease
- Chronic Spontaneous Urticaria
- Diabetes
- Eosinophilic Esophagitis
- Microbiota and Probiotics
- Multiple Myeloma
- Multiple Sclerosis
- Nasal Polyps
- Neurological Disorders
- Prurigo Nodularis
- Rare Diseases
- Transplant
- It's Praluent of Course
- Of Course
- What is PRALUENT®?
- Why choose PRALUENT®?
- How to use PRALUENT®?